| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: TTPH |
| Security Type |
Common Stock |
| Lead Underwriter |
Barclays BMO Capital Markets |
| Days In Registration |
36 |
| Date Filed |
11-Feb-2013 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2012) |
| Industry |
Manufacturing |
| Business Description |
Tetraphase Pharmaceuticals Inc, located in Watertown, Massachusetts, manufactures pharmaceuticals. The company is a clinical stage biopharmaceutical company using our proprietary chemistry technology to create novel antibiotics for serious and life-threatening multi-drug resistant infections. The company was founded in 2006. |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
17.49M |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
- |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
1607.14K |
| File Amount |
$86.25M |
| File Price Range |
- - - |
| File Mid Price |
- |
Current Filing Information
(Amended 19-Mar-2013) |
|
US |
|
Shares Filed |
8.33M |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
8.33M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$75.0M |
| · % Change from Original |
-13.04 |
| File Price Range |
$10.00 - $8.00 |
| File Mid Price |
$9.00 |
|
